From Crisis to Cures: Writing a New Prescription for Drug Development

Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching an Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists and clinicians to explore together how drugs work in complex systems.

Products You May Like

Articles You May Like

New Data Strengthen Case for Prechemotherapy Statins
Makeup Artist Gives Breast Cancer Survivors Free Makeovers
Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod to Treat Suspected Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection (“Flesh-Eating Disease”)
Watch live: Trump officials discuss Covid vaccines amid slow U.S. rollout
FDA Warns About Risk for False Negatives From Curative COVID Test

Leave a Reply

Your email address will not be published. Required fields are marked *